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Many different excipients are used in galenical pharmaceutical production, in addition to the active
pharmaceutical ingredients. Excipients are little investigated regarding their environmental fate and
impact, even though some of them are used in appreciable quantities. For 35 excipients used in galenical
production at Roche Basle and Roche Kaiseraugst, both in Switzerland, in the years 2013 and 2014, the
environmentally relevant properties were collated. A predicted environmental concentration (PEC) was
calculated for the wastewater treatment plants (WWTPs) and the receiving water, the River Rhine for
both sites, based on maximum daily losses of the single excipients to wastewater, derived by mass
balance, and the site-speciﬁc dilution factor. Predicted no effect concentrations (PNECs) were derived for
the WWTPs and the River Rhine. PECs and PNECs were compared for the WWTPs and the receiving
water, in an environmental risk assessment. Additionally, to simulate a worst case scenario, certain ga-
lenical productions where given excipients are used in the highest amounts were assumed to take place
in parallel on the same day, resulting in theoretical maximum excipient losses to wastewater. All PEC/
PNEC risk characterisation ratios for the excipients currently used by Roche in Switzerland are well below
1 throughout. Together with the fact that based on biodegradability data many excipients will be re-
moved in the WWTP, this indicates that the excipients currently used do not present a risk to the en-
vironment.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Galenical production of medicines needs excipients for various
purposes, e.g., to stabilise the active pharmaceutical ingredient
(API), lend bulk and colour to tablets, assist in breaking these up
in the stomach, control the time course of API release from the
formulation, disguise a bitter taste of the pure API, or other
functions (Swarbrick, 2015). The United States Pharmacopeia and
National Formulary (United States Pharmacopeia, 2014) lists 48
functional categories for excipients, from Adhesive overB.V. This is an open access article u
t; BOD5, Biochemical oxygen
A, Environmental risk as-
EC, No observed effect con-
for Economic Co-operation
centration; PNEC, Predicted
percentile) river ﬂow; QSAR,
-across; TOC, Total organic
roup SHE, 665/14, CH–4070
b).Antimicrobial Preservative, Bulking Agent and many others, to
Wetting/Solubilizing Agent. While in the USA and the European
Union (EU), new APIs need an environmental risk assessment
(ERA) for registration, there is no such requirement for excipients
(even though an older EU ERA draft did mention excipients
(Straub, 2002)). Excipients are being investigated regarding tox-
icological endpoints and quality standards (Kemsley, 2014), but
not for environmental risks. Only one publication so far, by Silva
et al. (2014), comparing algal toxicities of ﬂuoxetine in drug
products of differing compositions, i.e., containing varying ex-
cipients, suggested excipients to be responsible for manifestly
different toxicities. However, some excipients are being used in
comparatively high amounts in galenical production of medicines.
Therefore, we collated data and performed a site-speciﬁc ERA for
the wastewater treatment plants (WWTPs) and receiving water
for the excipients used in two galenical production sites of F.
Hoffmann‐La Roche Ltd (Roche) in Switzerland. To our knowledge,
the present contribution is the ﬁrst to investigate the potential
environmental risks arising from losses of excipients from gale-
nical production to wastewater.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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2.1. Excipient use amounts
An initial list of excipients was prepared by collating excipient
information from current or former, solid or liquid Roche drug
products worldwide, based on unpublished company-internal
documentation. Galenical production records at Roche Basle and
Kaiseraugst for the year 2013 and the ﬁrst six months of 2014 were
then consulted to identify those excipients actually being used at
those two sites. Maximum theoretical losses to wastewater were
calculated by mass balances for the single productions as de-
scribed by Hoerger et al. (2009). In brief, the ﬁnal products and all
documented losses were substracted from the total of active in-
gredients plus excipients, to result in worst-case losses, all of
which were assumed to be drained to wastewater in the ﬁrst
approximation.
Roche has two galenical production sites in Switzerland, viz.
Roche Basle and Roche Kaiseraugst, both situated on the River
Rhine, with Kaiseraugst approximately 13 km upriver from Basle.
Production of solid medicinal products (‘solida’; coated or un-
coated tablets, capsules, dry granulates (Hoerger et al., 2009)) in
general needs more excipients than the formulation of liquid
drugs (‘parenteralia’), e.g., due to the necessity for bulking or
disintegrating agents, colourants and lacquers. In contrast, solida
may be produced at up to 1000 kg per batch, with no or only little
liquid (water or alcohol) added for technical reasons. Solida are
mixed in large mixing units, in which at the end of the process a
thin layer of caked mixture of APIs and excipients may remain (see
Hoerger et al. (2009)). For cleaning, this cake is normally scraped
out manually and disposed of as special waste by incineration,
while the subsequent aqueous rinses from cleaning are discharged
to the WWTP. In some special cases, due to high ecotoxicity of the
API or in case of the API being categorized as ‘high-potency’ based
on toxicological or pharmacological reasons, the ﬁrst rinse (con-
taining most of the active substance remaining in the mixer) will
be separated and incinerated as well. Also, samples for quality
control, air ﬁlters, tablet breakage or mixtures and products not
meeting speciﬁcations will be incinerated. Substracting all those
categories disposed of by incineration from the total of APIs and
excipients weighed in, results in the worst case estimate of losses
to wastewater from solida production (Hoerger et al., 2009).
Parenteralia for Roche nearly exclusively means biologics, i.e.,
monoclonal antibodies and other biotechnologically produced pro-
tein APIs, usually of very high molecular mass 450,000 Da. As doses
are low, galenical batch sizes are comparatively small, up to 100 L per
batch for the two sites, moreover, most of the total consists of ul-
trapure water for formulation. Excipients are mainly organic buffers
(e.g., arginine, glutamine, glycine, histidine), often with a sugar (e.g.,
sucrose, trehalose) and a detergent (e.g., polysorbate 80); as an ex-
ample, see the SDS for MabThera SC (Safety Data Sheet for MabThera
SC, 2014). Parenteralia are mostly ﬁlled into glass vials, which are
then sealed, or into syringes. These containers are inspected visually
for cloudiness (signifying either undissolved solids or microbial
growth) and all units not passing are collected for incineration; the
same holds for the bags with residuals of ready mixed solutions or
mixtures not meeting speciﬁcations. Only liquid losses during the
mixing or the ﬁlling process, including possible breakages, are dis-
charged to wastewater. Substracting the incinerated and produced
amounts from the initial total results in the worst-case estimate of
losses from parenteralia production.
2.2. WWTP and receiving water data, predicted environmental
concentrations
Basic data for daily wastewater ﬂuxes and treatment for thetwo WWTPs serving Roche Kaiseraugst and Basle were searched
for as well as ﬂow data for the receiving water, which for both
WWTPs is the River Rhine. Predicted environmental concentra-
tions (PECs) for the WWTPs were calculated by dividing the worst-
case loss of excipients in grams per day by the average total
wastewater treated daily in the respective WWTP. Worst-case
PECs for the River Rhine were calculated by dividing the loss in g/d
by the minimum residual ﬂow or Q347 in Swiss terminology (the
long-term lower 5th percentile ﬂow (Swiss Federal Ofﬁce for the
Environment (BAFU), 2015c)) of the River Rhine in a day, i.e.,
without factoring in removal in the WWTPs through biodegrada-
tion or adsorption, hence in this ﬁrst approximation the WWTPs
do not inﬂuence the surface water PEC. In addition, as a worst-case
scenario, it was assumed that those productions with the highest
amounts of the same excipients would take place on the same day,
which leads to an inordinately high PEC for those substances.
Roche Kaiseraugst discharges the wastewater from galenical
production to WWTP Rhein in Pratteln, which treats approxi-
mately 15,800 m3 wastewater per day with an overall removal
efﬁciency of 98% regarding biochemical oxygen demand in 5 days
(BOD5) and of 90% regarding total organic carbon (TOC) (WWTP
Rhein, 2015). Basle galenical production discharges to WWTP
Basle, which treats approximately 93,100 m3/d with a removal
efﬁciency of 92.9% regarding BOD5 and 93.0% regarding TOC [data
for 2013, Ref. Pro Rheno Betriebs AG, 2013].
The River Rhine is the receiving water for both WWTP ef-
ﬂuents. It has a long-term (1891–2013) average ﬂow at the mea-
suring station Rheinhalle Basle of 1051 m3/s (Swiss Federal Ofﬁce
for the Environment (BAFU), 2014) and a minimum residual Q347
ﬂow of 459 m3/s (Swiss Federal Ofﬁce for the Environment (BAFU),
2014). The only two signiﬁcant surface water inﬂows into the
Rhine between the two WWTP efﬂuents are the smaller River Birs,
which has an average ﬂow of 14.6 m3/s and a monthly minimum
of 8.0 m3/s (Swiss Federal Ofﬁce for the Environment (BAFU),
2015a), and the River Wiese with an average of 9.6 m3/s and a
monthly minimum of 4.9 m3/s (Swiss Federal Ofﬁce for the En-
vironment (BAFU), 2015b). In a low-ﬂow situation for the River
Rhine, also the tributaries will carry little water; hence, the con-
tributions from the Birs and Wiese do not signiﬁcantly change the
Rhine ﬂow and will be disregarded for upstream (WWTP Rhein
efﬂuent) surface water PEC derivation.
2.3. Environmental data for excipients
Environmentally relevant substance data for these substances
were researched in company-internal documentation Roche Safety
Data Sheets (SDS) database and supplier SDS collection; older
hardcopy collections like Verschueren (1996)) as well as in online
databases and sources ChemIDPlus, Ref. ChemIDPlus database,
2015; Detergents Ingredients Database, 2014; European Chemicals
Agency (ECHA), 2015; Hazardous Substances Data Base (HSDB),
2015; ECOTOX Database, 2015; Environmental Fate Data Base
(EFDB), 2015 and on Scholar, 2015. The excipients were usually
identiﬁed by their Chemical Abstracts Services (CAS) numbers,
which was used for further data search. Search criteria included
molecular mass, physico-chemical data, ready (OECD 301) (Orga-
nisation for Economic Co-Operation and Development (OECD),
2015) or inherent (OECD 302) or model WWTP (OECD 303) bio-
degradability, algal growth inhibition (OECD 201 test or equiva-
lent), acute (OECD 202) or chronic (OECD 211) daphnid toxicity,
acute (OECD 203) or subchronic (OECD 210) to chronic ﬁsh toxicity
and activated sludge respiration inhibition (OECD 209) (Organi-
sation for Economic Co-Operation and Development (OECD),
2015), where available. In the ﬁrst step of the ERA, only experi-
mental biological data were used to ﬁll, as completely as possible,
a spreadsheet with the relevant informations on the excipients.
Table 1
Excipients used at Roche Basle and Kaiseraugst in 2013/2014 ordered by WWTP PEC, with their maximum PECs for single productions for the respective WWTP and the River Rhine, the corresponding PNECs with the references
used for their derivation, and the PEC/PNEC risk characterisation ratios.
Excipient CAS no. Wastewater treatment plant Receiving water (River Rhine)
PEC, mg/L PNEC, mg/L PNEC Ref. PEC/PNEC ratio PEC, ng/L PNEC, ng/L PNEC Ref. PEC/PNEC ratio
Starch 9005-25-8 3.79Eþ1 6.70Eþ4 (Zahn and Wellens, 1980) 5.70E04 8.90Eþ01 1.00Eþ05 (Detergents Ingredients Database, 2014) 8.90E04
Ethanol 64-1-5 3.08Eþ1 1.20Eþ4 (European Chemicals Agency (ECHA),
2015)
2.60E03 7.24Eþ01 9.60Eþ05 (European Chemicals Agency (ECHA), 2015) 7.54E05
D-Mannitol 69-65-8 2.12Eþ1 7.58Eþ4 [NRT] 2.79E04 4.97Eþ01 (1.00Eþ06) (European Chemicals Agency, 2006) (4.97E05)
Calcium phosphate 7757-93-9 2.05Eþ1 2.40Eþ2 RA (European Chemicals Agency
(ECHA), 2015)
8.50E02 4.82Eþ01 6.00Eþ04 RA (European Chemicals Agency (ECHA),
2015)
8.03E04
Cellulose 9004-34-6 1.92Eþ1 6.70Eþ4 (van der et al., 1994) 2.90E04 4.51Eþ01 1.00Eþ05 (Detergents Ingredients Database, 2014) 4.51E04
Lactose 10039-26-
6
1.63Eþ1 7.59Eþ4 [NRT] 2.15E04 3.83Eþ01 (8.10Eþ7) (US EPA, 2015) (4.73E7)
Crospovidone 9003-39-8 1.07Eþ1 3.00Eþ3 [NRT] 3.58E3 2.52Eþ01 8.40Eþ04 RA (BASF, 2015; Dvořáková et al., 1999) 3.00E04
Polyvinyl-pyrrolidone 9003-39-8 9.67Eþ0 2.00Eþ5 (BASF, 2015) 4.80E05 2.27Eþ01 8.40Eþ04 (BASF, 2015; Dvořáková et al., 1999; Heukele-
kian and Rand, 1955)
2.70E04
Sucrose 57-50-1 7.59Eþ0 1.00Eþ6 (Heukelekian and Rand, 1955; Gonza-
lez et al., 1972)
7.60E06 3.03Eþ00 (1.00Eþ06) (European Chemicals Agency, 2006) (3.03E06)
Talcum 14807-96-
6
6.77Eþ0 1.00Eþ4 (European Chemicals Agency (ECHA),
2015)
6.80E04 1.59Eþ01 NA NA
Sodium starch glycolate 9063-38-1 5.26Eþ0 3.00Eþ3 [NRT] 1.75E3 1.24Eþ01 NA NA
Titanium dioxide 13463-67-
7
4.83Eþ0 1.00Eþ4 (European Chemicals Agency (ECHA),
2015)
4.80E04 1.13Eþ01 6.00Eþ04 (European Chemicals Agency (ECHA), 2015) 1.89E04
Carboxmethyl cellulose 9000-11-7 3.54Eþ0 1.00Eþ5 (Detergents Ingredients Database,
2014)
3.50E05 8.32Eþ00 5.00Eþ05 (Detergents Ingredients Database, 2014) 1.66E05
Keltose 9005-31-6 3.11Eþ0 6.50Eþ4 [NRT] 4.79E05 7.31Eþ00 NA NA
Magnesium stearate 557-04-0 2.90Eþ0 8.83Eþ4 RA (European Chemicals Agency
(ECHA), 2015)
3.30E05 6.81Eþ00 9.00Eþ02 RA (European Chemicals Agency (ECHA),
2015)
7.56E03
Sorbitol 50-70-4 2.69Eþ0 1.00Eþ6 (Gonzalez et al., 1972; Straub, 2014) 2.70E06 6.32Eþ00 (1.00Eþ06) (European Chemicals Agency, 2006) (6.32E06)
Hydroxypropyl-methyl cellulose 9004-65-3 2.69Eþ0 6.70Eþ4 RA (van der et al., 1994) 4.00E05 6.31Eþ00 3.76Eþ04 (Detergents Ingredients Database, 2014) 1.68E04
Sodium stearyl fumarate 4070-80-8 1.40Eþ0 3.00Eþ3 RA (European Chemicals Agency
(ECHA), 2015)
4.70E04 3.28Eþ00 2.00Eþ03 RA (European Chemicals Agency (ECHA),
2015)
1.64E03
Sodium phosphate 7558-80-7 1.07Eþ0 2.40Eþ2 RA (European Chemicals Agency
(ECHA), 2015)
4.50E03 2.52Eþ00 6.00Eþ04 RA (European Chemicals Agency (ECHA),
2015)
4.20E05
Benzyl alcohol 100-51-6 9.46E1 3.90Eþ2 (European Chemicals Agency (ECHA),
2015)
2.45E03 2.22Eþ00 1.00Eþ04 (European Chemicals Agency (ECHA), 2015) 2.22E04
Sodium chloride 7647-14-5 7.73E1 5.00Eþ% (European Chemicals Agency (ECHA),
2015)
1.50E06 1.81Eþ00 3.72Eþ07 (European Chemicals Agency (ECHA), 2015) 4.88E08
Ethylcellulose 9004-57-3 7.52E1 1.00Eþ5 (Detergents Ingredients Database,
2014)
7.50E06 1.77Eþ00 1.00Eþ05 RA (Detergents Ingredients Database, 2014) 1.77E05
2-Methyl-oxirane, co-polymer with
oxirane
9003-11-6 7.52E1 4.00Eþ5 (Straub, 2014) 1.90E06 1.77Eþ00 1.00Eþ05 (Clariant, 2011) 1.77E05
Stearic acid 57-11-4 7.52E1 8.83Eþ4 (European Chemicals Agency (ECHA),
2015)
8.52E06 1.77Eþ00 9.00Eþ02 (European Chemicals Agency (ECHA), 2015) 1.96E03
Sodium dodecyl sulphate 151-21-3 6.45E1 1.35Eþ3 (European Chemicals Agency (ECHA),
2015)
4.77E04 1.51Eþ00 4.00Eþ03 (European Chemicals Agency (ECHA), 2015) 3.78E04
Sodium citrate 1545-80-1 6.31E1 1.00Eþ6 RA (European Chemicals Agency
(ECHA), 2015)
6.30E07 1.48Eþ00 1.60Eþ06 RA (European Chemicals Agency (ECHA),
2015)
9.26E07
Silicic acid 7631-86-9 4.08E1 NA NA 9.58E01 4.22Eþ04 (European Chemicals Agency (ECHA), 2015) 2.27E05
Polyethylene glycol 25322-68-
3
3.22E1 1.00Eþ5 (Clariant, 2011) 3.20E06 7.56E01 1.00Eþ05 (Chemie, 2014) 7.56E06
L-Histidine 71-00-1 1.99E1 1.00Eþ4 (Helfgott et al., 1977) 1.99E05 4.67E01 (4.35Eþ4) (US EPA, 2015) (1.07E5)
Sodium acetate 6131-90-4 1.85E1 1.15Eþ5 RA (European Chemicals Agency
(ECHA), 2015)
1.60E06 4.33E01 1.00Eþ05 RA (European Chemicals Agency (ECHA),
2015)
4.33E06
Succinic acid 110-15-6 1.77E1 3.00Eþ4 (European Chemicals Agency (ECHA),
2015)
5.90E06 7.06E02 4.07Eþ04 (European Chemicals Agency (ECHA), 2015) 1.73E06
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K.C. Wirz et al. / Sustainable Chemistry and Pharmacy 1 (2015) 28–35 31Quantitative structure–activity relationship (QSAR)-modelled data
using EPISuite (US EPA, 2015) for acute ecotoxicity were only used
in a second step for insufﬁciently documented, simple com-
pounds; however, no QSAR data were derived for polymers.2.4. Predicted no-effect concentrations
This spreadsheet served as a basis for a general overview, but
also for deriving predicted no-effect concentrations (PNECs) for
WWTPs and receiving (fresh) waters. PNECs were calculated ac-
cording to the EU Technical Guidance Document (European Com-
mission, 2003) as follows. For WWTP PNECs, the activated sludge
respiration inhibition (OECD 209) (Organisation for Economic Co-
Operation and Development (OECD), 2015) 50% effect concentra-
tion (EC50) was divided by an assessment factor of 100 to arrive at
the PNEC; where a no observed effect concentrations (NOEC) was
available, this was divided by an assessment factor of 10; the
NOEC-based PNEC was given preference over the EC50-based. Al-
ternatively, if no activated sludge respiration inhibition test data
were available, but conﬁrmation of ready or inherent biodegrad-
ability instead, one-tenth of the biodegradation test concentration
was used as a surrogate WWTP PNEC.
In a few select cases, where no biodegradation or activated
sludge respiration inhibition information was found for common
excipients used in higher amounts, inherent biodegradation tests
were performed in the Roche Basle environmental laboratory ac-
cording to internal protocols, which correspond to a Zahn–Wellens
test (based on OECD 302B) or a manometric respirometry test
(OECD 302C) (Organisation for Economic Co-Operation and De-
velopment (OECD), 2015). The Zahn–Wellens tests were usually
run for 14 days with a test substance concentration corresponding
to 300 mg dissolved organic carbon/L and a 1:1 mix of rinsed ac-
tivated sludge from an industrial and a predominantly municipal
WWTP at 1000 mg dry weight/L. If the test substance was in-
herently degradable in the Zahn Wellens test, it was assumed that
the high test substance concentration was not inhibitory to acti-
vated sludge. The respirometry tests were run for 28 days with a
test substance concentration of 30 mg/L and the same mixed
sludge as above at 100 mg dry weight/L. In addition, for the re-
spirometry tests an inhibition/toxicity control was run in parallel
with 30 mg test substance/L plus 30 mg sodium benzoate/L; if the
biodegradation of sodium benzoate progressed normally in the
presence of the test substance, the test substance was assumed not
to inhibit the activated sludge.
For freshwater PNECs, in the case of three available EC50s from
algae and daphnia and ﬁsh, the lowest EC50 was divided by an
assessment factor of 1000; in case of two (sub)chronic NOECs from
two of the three organism groups, the lowest was divided by 50; in
case of three NOECs (one from each groups), the lowest was di-
vided by 10. PNECs derived from chronic toxicity results were gi-
ven preference over acute-based PNECs. In a few cases where in-
sufﬁcient data were available, read-across from closely related
substances was used for PNECs, e.g., for acetates from acetic acid,
or for ethylcellulose from cellulose.2.5. Environmental risk assessment
The risk characterisation for the two WWTPs and the River
Rhine was made by dividing the PECs by the PNECs for the single
excipients. PEC/PNEC ratios o1 suggest no signiﬁcant risk while
PEC/PNEC ratios Z1 mean potential risk (European Commission,
2003).
K.C. Wirz et al. / Sustainable Chemistry and Pharmacy 1 (2015) 28–35323. Results
3.1. Excipients used at Roche Basle and Kaiseraugst 2013/2014
In 2013 and the ﬁrst half of 2014, a total of 15 different drug
products were formulated at Roche Basel and Kaiseraugst, several
more than once. While Basle produces both solid and liquid do-
sage forms, Kaiseraugst formulates only parenteralia. Eight of
these 15 products were biologics (i.e., parenteralia), the remaining
seven were chemically synthesised, small-molecule APIs (i.e., so-
lida). For these galenical productions, 35 different excipients out of
the general list above were used at both sites (Table 1).
Values in brackets are derived from QSAR ecotoxicity data; in
case of D-mannitol, sorbitol and sucrose, an EU reference (Eur-
opean Chemicals Agency, 2006) used QSAR data; for the other
substances in brackets, EPISuite (US EPA, 2015) QSAR data were
developed to ﬁll in the blanks. Minor discrepancies between PECs,
PNECs and PEC/PNEC ratios are due to rounding errors. NA¼not
available; [NRT]¼new Roche internal tests; RA¼read-across.
3.2. WWTP and river Rhine PECs
3.2.1. WWTP PECs
The WWTP PECs range from 37.9 mg/L for starch to 0.0225 mg/L
for sodium dioctyl sulfosuccinate, spanning three orders of mag-
nitude (Table 1); both extremes refer to the Basle WWTP. Also high
on the list with WWTP PECs 45 mg/L are ethanol (PEC¼30.8 mg/
L), mannitol (21.2 mg/L), calcium phosphate (20.5 mg/L), cellulose
(19.2 mg/L), lactose (16.3 mg/L), crospovidone (10.7 mg/L), poly-
vinylpyrrolidone (9.67 mg/L), sucrose (7.59 mg/L), talcum (6.77 mg/L)
and sodium starch glycolate (5.26 mg/L).
The WWTP PECs show that the highest use excipients are
starch and certain sugars, ethanol, cellulose, two poly-
vinylpyrrolidones and inorganic talcum, while pH regulators/buf-
fers and detergents on the whole are at the lower end. With the
exception of sucrose all of these major excipients are exclusively
used in solida production. This conﬁrms that (apart from ethanol)
bulking agents, diluents, disintegrating aids and lubricants show
the biggest masses, as would have been expected. Ethanol in solida
is used for wetting dry mixtures and will evaporate during the
granulating and tablet-pressing processes or during tablet storage.
3.2.2. River Rhine PECs
The worst-case crude PECs for the River Rhine, calculated
without removal in a WWTP through either biodegradability or
sorption and assuming long-term Q347 low ﬂow conditions, show
the same distribution, ranging from starch (89.0 ng/L) to sodium
dioctyl sulfosuccinate with 50.4 pg/L (Table 1). The same 11 ex-
cipients as above, plus titanium dioxide, have PECs 410 ng/L
while 9 compounds have PECs o1 ng/L.
The PECs derived here are worst-case in the sense that both all
unaccounted-for amounts are assumed to be discharged to was-
tewater, that no biodegradation in the WWTP takes place for any
of them and that the receiving water dilution is the Q347 low ﬂow.
Regarding losses from production, those solida productions in-
volving so-called ‘high-potency’ APIs have the ﬁrst rinse of the
mixers separated and sent to incineration as a Standard Operating
Procedure; the same applies to a few other solida productions of
non-biodegradable APIs formulated in higher amounts [Roche-
internal data]. Hence, a major part of residual APIs and excipients
from certain productions will not be discharged to wastewater.
The assumption of no removal in WWTPs is not supported by
the available data, either. Out of the organic high WWTP PEC
compounds (PEC 45 mg/L), starch is readily biodegradable (Zahn
and Wellens, 1980), ethanol is readily biodegradable beside being
stripped during aeration [Roche-internal data], D-mannitol andlactose are well inherently degradable in new Roche-internal tests,
cellulose is readily biodegradable (van der et al., 1994), sucrose is
readily biodegradable (Gonzalez et al., 1972) or at least ‘biode-
gradable’ (Straub, 2014), and sodium starch glycolate is ‘biode-
gradable’ (Straub, 2014) and proved to be inherently biodegrad-
able in a new Roche-internal test. While polyvinylpyrrolidone is
listed as inherently biodegradable in the EU Detergents In-
gredients Database (Detergents Ingredients Database, 2014), both
crospovidone and polyvinylpyrrolidone were not inherently bio-
degradable in the new Roche-internal tests.
Last, the 1891–2013 average Q347 (2013 being the most recent
Q347 available) River Rhine ﬂow of 459 m3/s (Swiss Federal Ofﬁce
for the Environment (BAFU), 2014) is a very conservative as-
sumption compared to the average ﬂow of the whole 1891–2013
period of 1051 m3/s (Swiss Federal Ofﬁce for the Environment
(BAFU), 2014). All three arguments suggest that the WWTP and
particularly the River Rhine PECs are decidedly on the high side.
Hence, the highest WWTP PEC of 37.9 mg/L and the corresponding
River Rhine PEC (without removal) of 89.0 ng/L, both for starch,
are clearly worst-case ﬁgures. Using the long-term average ﬂow of
1051 m3/s (Swiss Federal Ofﬁce for the Environment (BAFU), 2014)
for dilution, even without considering removal in the WWTPs, the
highest River Rhine PEC for starch decreases to 38.9 ng/L. In par-
allel, only seven out of the original 12 excipients remain with a
PEC 410 ng/L, while there are 16 (formerly nine) excipients with
PECs o1 ng/L (data not shown). Out of these seven excipients, one
is inorganic (calcium phosphate), while the removal-reﬁned PECs
of ﬁve (starch, ethanol, D-mannitol, cellulose and lactose) are
predicted to decrease below 10 ng/L, and only crospovidone, being
non-degradable, would maintain its average-ﬂow PEC of 11.0 ng/L
(data not shown).
3.3. Excipient PNECs
3.3.1. WWTP PNECs
All excipients from galenical productions show WWTP PNECs
ranging from 240 mg/L (calcium phosphate, read-across from
phosphoric acid (European Chemicals Agency (ECHA), 2015) to
1,000,000 mg/L (sodium citrate, read-across from citric acid (Eur-
opean Chemicals Agency (ECHA), 2015 Sorbitol and sucrose both
have their PNEC based on Straub (2014), while the PNEC for so-
dium stearyl fumarate is read-across from the lower PNEC of
stearyl alcohol and fumaric acid (European Chemicals Agency
(ECHA), 2015). Seven (starch, ethanol, mannitol, cellulose, lactose,
L-histidine, sodium starch glycolate) of the remaining excipients
are biodegradable [25, 27, 28, 31–34, 36, new Roche-internal tests],
hence one-tenth of the biodegradability testing concentration was
used as a substitute WWTP PNEC (Table 1). Crospovidone was not
degradable in a new Roche-internal manometric respirometry
test; however, there was no inhibition of co-substrate biode-
gradation, hence 3 mg crospovidone/L was used as a WWTP PNEC
(Table 1). Hydroxypropylmethylcellulose is listed as non-biode-
gradable but showing 100% removal in the Detergents Ingredients
Database (Detergents Ingredients Database, 2014); this is inter-
preted to mean that the substance was not toxic to activated
sludge, but adsorbed to it, hence the PNEC from cellulose
(67,000 mg/L (van der et al., 1994)) was read-across. No direct or
read-across WWTP PNEC could be derived for silicic acid; how-
ever, in the crystal form used silicic acid is an inert substance and
is not expected to show toxicity to bacteria.
3.3.2. Surface water PNECs
The freshwater PNECs of the excipients range from 37,200 mg/L
for sodium chloride (European Chemicals Agency (ECHA), 2015) to
0.9 mg/L for stearic acid (European Chemicals Agency (ECHA),
2015). In the following cases, the PNECs were derived by read-
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phoric acid, crospovidone from polyvinylpyrrolidone, magnesium
stearate from stearic acid, sodium acetate from acetic acid, and
ethylcellulose from cellulose. For hydroxypropylmethyl cellulose,
the PNEC of 0.037 mg/L from the EU Detergents Ingredients Da-
tabase (Detergents Ingredients Database, 2014) was originally
derived from only two ecotoxicity data using an increased as-
sessment factor of 5000; note that reading across from cellulose
would give a PNEC of 0.1 mg/L, nearly three times higher. The
PNECs for D-mannitol, sorbitol and sucrose were derived from an
EU document (European Chemicals Agency, 2006) that used QSAR
ecotoxicity data, see Section 4. For lactose and L-histidine, the
lowest acute QSAR ecotoxicity data for algae, daphnia and ﬁsh
predicted by EPISuite (US EPA, 2015) were used to derive a sub-
stitute PNEC. Thus, three excipients out of the 35 have no PNEC
due to the unavailability of sufﬁcient ecotoxicity data or the high
uncertainty of modelling them, the inorganic magnesium silicate
talcum and the organic polymers sodium starch glycolate and
keltose.
Surface water PNECs could be derived for 32 of the 35 ex-
cipients, but not for the remaining three (in order of PEC, talcum,
sodium starch glycolate and keltose), due to lack of available
ecotoxicity data. While none of those three data-poor excipients
are suspected to exert any speciﬁc toxicity or to be a risk for re-
ceiving waters, it still means that no formal ERA is possible but
that an assessment based on plausibility considerations must be
developed. Talcum is a nearly insoluble inorganic magnesium si-
licate, sodium starch glycolate is a naturally extracted product
from cereals or potatoes, and keltose is the ammonium salt of
alginic acid, a linear block co-polymer of guluronic acid and
mannuronic acid of natural algal origin. Hence, all organic com-
pounds are natural or quasi natural products.
A QSAR-based PNEC was used for sucrose, D-mannitol and
sorbitol (European Chemicals Agency, 2006). In algae, low-mole-
cular-weight carbohydrates including various common natural
sugars and sugar alcohols (beside starch) are biosynthesized and
function both as organic carbon and energy store, solutes, oxygen
scavengers and building blocks for larger cell wall carbohydrates
(Raven and Beardall, 2012), with mannitol being speciﬁcally
mentioned as an example for the kelp Laminaria. To use the sugars,
algae have glycolytic enzymes that would allow them to meta-
bolise many different kinds of simple sugars and sugar alcohols. In
Daphnia pulex, short-term exposure to lactose caused a reversible
change in heart rate; however, the NOEC was a high 20 mM or
6.85 g/L (Campbell et al., 2004); in the same paper, sucrose and
galactose had a NOEC of 100 mM each, corresponding to 34.2 g/L
and 18.0 g/L, respectively. Fish, as vertebrates, are obviously closer
to mammals, even though there is evidence that ﬁsh on the whole
are relatively insulin- and glucose-resistant [reviewed in Hemre
et al. (2002)]. Overall, natural sugar and sugar alcohol compounds
are not regarded as inordinately toxic to algae, daphnia or ﬁsh.
Indeed, the European Chemicals Agency has had the substances
for Annex IV of the REACH chemicals legislation reviewed (Eur-
opean Chemicals Agency, 2006); Annex IV contains those sub-
stances where ‘sufﬁcient information is known about these sub-
stances that they are considered to cause minimum risk because of
their intrinsic properties’ (European Commission, 2015). In this
review document (European Chemicals Agency, 2006), sucrose
and the sugar alcohols mannitol and sorbitol are considered to
have sufﬁcient information for inclusion. The document refers to
QSAR data for both ready biodegradability and low ecotoxicity, the
latter resulting in surface water high PNECs 41 g/L for all three
compounds.
Similarly, EPISuite QSAR modelling (US EPA, 2015) was used for
the simple organics lactose and L-histidine. However, for the in-
organic talcum and the organic polymers sodium starch glycolateand keltose, no useful PNEC could be derived. Their respective
worst-case surface water PECs in the River Rhine are 15.9, 12.4 and
7.3 ng/L, moreover, both organic polymers proved to be inherently
biodegradable in the new Roche-internal tests, decreasing their
surface water PECs. All three excipients would need to exert an
inordinately high, speciﬁc ecotoxicity to have a PNEC of a magni-
tude of approximately 10 ng/L; this is not expected.
3.4. PEC/PNEC risk characterisation ratios
All PEC/PNEC quotients that can be derived for WWTPs and the
River Rhine are o0 (Table 1). This means that for these excipients
there is no reason to assume any signiﬁcant risk either to WWTPs
or the the receiving water. The highest WWTP risk characterisa-
tion ratio of 0.085 is for calcium phosphate, not because of an
inordinately high WWTP PEC (20.5 mg/L) but rather because the
WWTP PNEC was derived from phosphoric acid by read-across.
The other WWTP risk quotients decrease to 2.80E7 for acetic
acid. One substance, silicic acid, has no basic data at all to derive a
WWTP PNEC, thus preventing WWTP risk assessment.
For the surface waters, the highest risk characterisation ratio is
0.00756 for magnesium stearate; again, this was read-across from
stearic acid, which had low ecotoxicity NOECs due to very low
water solubility (European Chemicals Agency (ECHA), 2015). The
other surface water risk quotients decrease to 4.88E8 for sodium
chloride. Due to lack of experimental or other published data to
base a PNEC on, no risk quotient can be derived for talcum, sodium
starch glycolate and keltose.
3.5. Risk characterisation ratios for parallel productions
In the theoretical worst case of three parallel productions with
different APIs, selected for the maximum amounts of excipients,
the highest compound losses would be for lactose (WWTP PEC
59.5 mg/L, River Rhine PEC 140 ng/L), cellulose (WWTP 51.0 mg/L,
Rhine 120 ng/L) and starch (WWTP 45.6 mg/L, Rhine 107 ng/L);
again, the Rhine PECs were derived without considering biode-
gradation or adsorption in the WWTP. The corresponding risk
characterisation ratios for lactose are 0.020 in the WWTP and
4.73E7 (based on a QSAR-derived PNEC) in the Rhine; for cel-
lulose 0.00076 (WWTP) and 0.0012 (Rhine), and for starch 0.0068
(WWTP) and 0.0011 (Rhine). Based on the available data, even
with three comparatively high-loss productions coinciding, no
signiﬁcant risk to the WWTPs or to the River Rhine is apparent.
One minor caveat remains for lactose, where no experimental
ecotoxicity data are available, but only QSARs, to derive a solid
surface water PNEC.
3.6. A broader view
Out of the 35 compounds, three are insufﬁciently documented
for surface water PNEC derivation and initial ERA. Extending the
data search to a bigger set of 184 former or current excipients used
in Roche drug products from Swiss or other production sites (data
not shown), presents a bleaker picture. The biggest single cate-
gories are sugars and sugar alcohols, detergents and buffers. Suf-
ﬁcient ecotoxicity data allow the derivation of at least an acute-
based PNEC for nearly all buffers and detergents and most alco-
hols, amines, solvents, silicates and inorganic salts. However, these
are lacking for two thirds of the sugar and sugar alcohol groups,
also, particularly amino acids, peptides, celluloses and oils/fats are
poorly documented. As natural substances the latter are not ex-
pected to exert signiﬁcant toxicity, but still, sufﬁcient environ-
mental data for a PNEC were located for only about half of the 184
excipients, all others lack data.
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All risk quotients that can be derived for single excipients have a
value well below 1, both for the WWTPs and the River Rhine. The
same holds for the assumption of parallel productions. Even summing
up all the risk characterisation ratios (except for those substances
where no PNEC can be derived) results in a compound risk quotient of
still o1 for the WWTPs and the River Rhine. This strongly suggests
that excipients lost to wastewater from galenical production at the two
Roche sites in Switzerland do not present a risk to the environment.
However, pharmaceuticals are not only formulated by one com-
pany in Switzerland. This means that the number and data availability
of the excipients, but also the parameters of the WWTPs and the re-
ceiving waters, may be quite different for other products and coun-
tries. As stated above, sufﬁcient environmental data for a PNEC were
located for just about half of the extended dataset of 184 excipients.
While these compounds should not be a concern from a toxicological
point of view, and with some probability also from an ecotoxicological
one, the basic data situation is pretty thin. Obviously, more basic en-
vironmental data on excipients would improve this situation and, in-
deed, since the beginning of the European Union Chemicals Pro-
gramme REACH, many more relevant data have become publicly
available through the REACH internet database.
Still, even those surface water PNECs that could be derived are
not all of the same quality, in the sense that they rely on different
basic data. Most PNECs are based three acute ecotoxicity tests with
an assessment factor of 1000 applied to the lowest EC50, some on
two chronic NOECs with an assessment factor of 50, a few on three
chronic NOECs and an assessment factor of 10, while for some
excipients either a higher assessment factor is included due to
insufﬁcient tests available, or read-across data from related com-
pounds, or QSAR-modelled ecotoxicity data; ﬁnally, for a few, no
PNEC could be derived. Thus, there is potentially a signiﬁcant
variability in the quality of PNECs and therefore a range of un-
certainty, which may limit their direct comparability.
The relationship between acute (EC50, LC50) values and
chronic NOEC or LOEC values for the same group of organisms has
been investigated by several groups over time, e.g., Roex et al.,
(2000) and Kienzler et al., (2015). In particular for non-polar nar-
cotics and for molar concentrations of the test substance, these
authors consistently found overall correlations of the type
log(chronic NOEC or LOEC)¼factor  log(EC50 or LC50) –
constant, with the factor deﬁning the slope of the regression gen-
erally being smaller than 1. Such a slope means that for the same
group, on the whole, the relationship between chronic and acute
endpoints is less than 10, plus or minus the constant. Simi-
larly, Ahlers et al. (2006) found median acute-to-chronic ratios up to
12.7; however, single ratios for speciﬁc substances may be much
higher. For unspeciﬁcally acting, narcotic substances; however, an
acute-based PNEC should be reasonably close to the chronic-based
PNEC. For those PNECs derived by read-across or QSAR, again for
narcotic substances, ECETOC (ECETOC, 2012) concluded that such
derivations are acceptable, moreover, REACH also accepts QSAR-
developed ecotoxicity data for unproblematic substances. As ex-
cipients, in view of their functions, are not reactive substances on
the whole, but rather acting by unspeciﬁc narcosis, the uncertainty
arising from comparing acute- and chronic-based PNECs should
therefore be reasonably low. However, in view of the disparate
database for the excipients, some inherent uncertainty in the PNECs
should be acknowledged, even if it cannot be quantiﬁed.
Assuming reasonable wastewater treatment everywhere, an-
other major difference may be in the local receiving water. The
River Rhine is quite a large water body with a correspondingly
high dilution factor, but this is not necessarily the case for other
sites and receiving waters. Within the Roche Group, average re-
ceiving water dilution factors of galenical site WWTP efﬂuents varyconsiderably, over approximately three orders of magnitude [Roche
unpublished data]. This means that the PECs for the same (theo-
retical) amount of excipient lost to wastewater at different sites
would also vary in the same dimension – and the risk character-
isation ration might increase by the same factor. Based on the
current set of 35 excipients, stearic acid and its salts or esters might
attain surface water risk characterisation ratios of around 1 based
on the present data. Hence, the biodegradability (stearic acid is
readily biodegradable (European Chemicals Agency (ECHA), 2015)
and predicted removal in a WWTP as well as the solubility and
potential PNEC limitations deriving from this, should be taken into
account in a reﬁned ERA. On a broader scale, the unknown situation
at other production sites can only be addressed, and potential risks
from excipient losses during galenical production can only be in-
vestigated, by site-speciﬁc ERA, in particular for those production
sites that have a comparatively low receiving water dilution factor.5. Conclusions
An initial ERA was performed for excipient losses from solida and
parenteralia galenical production at Roche Basel and Kaiseraugst in
Switzerland, which resulted in the overall conclusion of no signiﬁcant
risk, both for single excipients, all excipients added together and for
parallel productions. However, for a larger set of excipients, the en-
vironmental basic data situation for common compounds was re-
vealed to be unsatisfactory. For the above sites there is no indication of
potential negative effects from galenical production: the excipients
pose no signiﬁcant risk as detailed in this work, APIs for solida were
risk-assessed some years ago without highlighting environmental
problems (Hoerger et al., 2009) and there is good evidence that bio-
logics active ingredients do not present a risk, either (Straub, 2010).
Still, in particular for sites with comparatively low receiving water
dilution factors, or for other, insufﬁciently documented excipients, a
site-speciﬁc ERA would clarify the situation.Conﬂict of interest
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